CoChat

Role of Bile Acid Sequestrants in the Treatment of Type 2 Diabetes

Open access
Handelsman, Yehuda · 2011 · Diabetes Care
Cited by 81

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Type 2 diabetes is a complex diseasethat requires lifestyle modificationand often pharmacological therapy. There are a variety of effective oral anti-diabetes agents to help control type 2 diabetes, thereby providing the opportu-nity for clinicians to select specific treat-ment(s) that meet the individual needs of a patient. This is particularly important for patients with type 2 diabetes, who often have comorbidities that can compli-cate the management and limit the phar-macological options for treatment. This review discusses the rationale for using a bile acid sequestrant (BAS) for the treat-ment of type 2 diabetes, the clinical effects of the only BAS approved for both glycemic and lipid control in the U.S. (colesevelam hydrochloride), and the appropriate place in type 2 diabetes therapy for a BAS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc11-s237

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 81

Metadata

Authors
Handelsman, Y.
Venue
Diabetes Care
Published
2011-04-22
Volume
34
Issue
Supplement_2
Pages
S244-S250
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2151467742
Cited by
81
References
6
FWCI
4.71
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Role of Bile Acid Sequestrants in the Treatment of Type 2 Diabetes. https://app.cochat.ai/papers/10.2337/dc11-s237
The paper
Handelsman, Y. (2011). Role of Bile Acid Sequestrants in the Treatment of Type 2 Diabetes. Diabetes Care. https://doi.org/10.2337/dc11-s237

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.